Barbara A. Payne's most recent trade in Utah Medical Products, Inc. was a trade of 500 Common Stock done at an average price of $90.0 . Disclosure was reported to the exchange on Feb. 8, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Utah Medical Products Inc | Barbara A. Payne | Director | 08 Feb 2023 | 500 | 4,838 (0%) | 0% | 90.0 | 44,999 | Common Stock | |
| Utah Medical Products Inc | Barbara A. Payne | Director | 11 May 2022 | 2,000 | 5,338 (0%) | 0% | 85.2 | 170,397 | Common Stock | |
| Utah Medical Products Inc | Barbara A. Payne | Director | 09 Feb 2022 | 500 | 7,338 (0%) | 0% | 98.9 | 49,470 | Common Stock | |
| Utah Medical Products Inc | Barbara A. Payne | Director | 17 Nov 2021 | 1,249 | 7,838 (0%) | 0% | 111.1 | 138,717 | Common Stock | |
| Utah Medical Products Inc | Barbara A. Payne | Director | 17 Nov 2021 | 751 | 9,087 (0%) | 0% | 111.1 | 83,408 | Common Stock |